SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020089
Filing Date
2020-10-29
Accepted
2020-10-29 07:30:26
Documents
76
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 541843
2 ex31-1.htm EX-31.1 19637
3 ex31-2.htm EX-31.2 19597
4 ex32-1.htm EX-32.1 7301
5 ex32-2.htm EX-32.2 7066
  Complete submission text file 0001493152-20-020089.txt   3385792

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtnt-20200930.xml EX-101.INS 512605
7 XBRL SCHEMA FILE xtnt-20200930.xsd EX-101.SCH 47549
8 XBRL CALCULATION FILE xtnt-20200930_cal.xml EX-101.CAL 65338
9 XBRL DEFINITION FILE xtnt-20200930_def.xml EX-101.DEF 140967
10 XBRL LABEL FILE xtnt-20200930_lab.xml EX-101.LAB 328973
11 XBRL PRESENTATION FILE xtnt-20200930_pre.xml EX-101.PRE 247662
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 201270533
SIC: 2836 Biological Products, (No Diagnostic Substances)